儿科羟基脲 III 期临床试验-猫眼课题宝

儿科羟基脲 III 期临床试验

批准号：

6357892

负责人：

SOHAIL RANA

金额：

$0.0万

依托单位：

HOWARD UNIVERSITY

依托单位国家：

美国

项目类别：

财政年份：

2000

资助国家：

美国

项目状态：

已结题

起止时间：

2000-09-01 至 2006-07-31

来源：

https://reporter.nih.gov/project-details/6357892

关键词：

blood disorder chemotherapy chemoprevention clinical research human subject human therapy evaluation hydroxyurea infant human (0-1 year) longitudinal human study multiple organ failure pathologic process preschool child (1-5) sickle cell anemia

项目摘要

项目成果

SOHAIL RANA的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

BABY HUG is a randomized, double-blind, placebo-controlled trial to determine if hydroxyurea can prevent the onset of chronic end organ damage in young children with sickle cell anemia. BABY HUG follows the successful completion of two other sickle cell disease trials, the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) and the Pediatric Hydroxyurea (PED HUG) Trial. Approximately 200 children, ages six months to 24 months, with sickle cell disease will be recruited to receive either hydroxyurea or placebo. The children will be screened at trial start-up for signs of abnormal brain, renal, pulmonary, and splenic function, and for developmental milestones. They will then be randomly assigned to receive hydroxyurea or a placebo and followed with yearly studies of chronic end organ damage of the major organ systems.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文